Ali Shakeri Abroudi

Mr. Ali Shakeri Abroudi

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2024 in Discover Oncology
Verified
Journal Article
Open access
PDF file
Danial Hashemi KaroiiDanial Hashemi Karoii
Danial Hashemi Karoii
SBSobhan Bavandi
Sobhan Bavandi
MDMelika Djamali
Melika Djamali
AAAli Shakeri Abroudi
Ali Shakeri Abroudi
Background The rise of treatment resistance and variability across malignant profiles has made precision oncology an imperative in today’s medical landscape. Prostate cancer is a prevalent form of cancer in males, characterized by significant diversity in both genomic and clinical characteristics. The tumor microenvironment consists of stroma, tumor cells, and various immune cells. The stromal components and tumor cells engage in mutual communication and facilitate the development of a low-oxygen and pro-cancer milieu by producing cytokines and activating pro-inflammatory signaling pathways. Methods In order to discover new genes associated with tumor cells that interact and facilitate a hypoxic environment in prostate cancer, we conducted a cutting-edge bioinformatics investigation. This included analyzing high-throughput genomic datasets obtained from the cancer genome atlas (TCGA). Results A combination of weighted gene co-expression network analysis and single-cell sequencing has identified nine dysregulated immune hub genes (AMACR, KCNN3, MME, EGFR, FLT1, GDF15, KDR, IGF1, and KRT7) that are believed to have significant involvement in the biological pathways involved with the advancement of prostate cancer enviriment. In the prostate cancer environment, we observed the overexpression of GDF15 and KRT7 genes, as well as the downregulation of other genes. Additionally, the cBioPortal platform was used to investigate the frequency of alterations in the genes and their effects on the survival of the patients. The Kaplan-Meier survival analysis indicated that the changes in the candidate genes were associated with a reduction in the overall survival of the patients. Conclusions In summary, the findings indicate that studying the genes and their genomic changes may be used to develop precise treatments for prostate cancer. This approach involves early detection and targeted therapy.

19 June 2025 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
AAAli Shakeri Abroudi
Ali Shakeri Abroudi
HAhossein Azizi
hossein Azizi
MDMelika Djamali
Melika Djamali
HAHewa Khalid Abdullah
Hewa Khalid Abdullah
AQAli Qorbanee
Ali Qorbanee
STSkutella Thomas
Skutella Thomas

Verified
Journal Article
Open access
PDF file
AAAli Shakeri Abroudi
Ali Shakeri Abroudi
MMMahtab Mashhouri Moghaddam
Mahtab Mashhouri Moghaddam
Danial Hashemi KaroiiDanial Hashemi Karoii
Danial Hashemi Karoii
MDMelika Djamali
Melika Djamali
HAhossein Azizi
hossein Azizi
STSkutella Thomas
Skutella Thomas
A complex and gradual process, the epithelial–mesenchymal transition (EMT) occurs both during embryonic development and tumor progression. Cells undergo a transition from an epithelial to a mesenchymal state throughout this process. More and more evidence points to EMT as a cause of increased metastatic spread of prostate cancer (PCa), along with stemness enhancement and therapy resistance. Here, we used bioinformatic methods to analyze gene expression microarray data, single-cell RNA sequencing, oncogenes, and tumor suppressor genes (TSGs) in order to reconstruct the network of differentially expressed genes (DEGs) involved in the epithelial–mesenchymal transition with PCa. No prior study has documented this sort of analysis. We next validated our results using data from the Cancer Genome Atlas (TCGA), which included microarray and single-cell RNA sequencing. Potentially useful in PCa diagnosis and treatment are extracellular matrix in epithelial–mesenchymal transition genes, including ITGBL1, DSC3, COL4A6, ANGPT1, ARMCX1, MICAL2, and EPHA5. In this study, we aimed to shed light on the molecular characteristics and pathways of DEGs in PCa, as well as to identify possible biomarkers that are important in the development and advancement of this cancer. These insights have important implications for understanding prostate cancer progression and for the development of therapeutic strategies targeting ECM-mediated pathways.

13 February 2025 in Discover Oncology
Verified
Journal Article
Open access
PDF file
Danial Hashemi KaroiiDanial Hashemi Karoii
Danial Hashemi Karoii
AAAli Shakeri Abroudi
Ali Shakeri Abroudi
NFNadia Forghani
Nadia Forghani
SBSobhan Bavandi
Sobhan Bavandi
MDMelika Djamali
Melika Djamali
EHEhsan Hasanzadeh
Ehsan Hasanzadeh
Background Prostate cancer (PCa) is the second most common malignant neoplasm in males and is the fifth leading cause of cancer-related mortality. Due to the use of prostate-specific antigen (PSA) screening and improved biopsy techniques, persons identified with early-stage prostate cancer often have a positive prognosis after comprehensive treatment. Nonetheless, prostate cancer is a latent illness that may present as an asymptomatic tumor in individuals aged 20–30. The overall survival (OS) of men with advanced PCa is significantly diminished. Consequently, there is an immediate want for innovative, accurate biomarkers to detect early prostate cancer. Methods This research analyzed the interaction network of differentially expressed genes (DEGs) related to metabolite interconversion enzymes in PCa by gene expression microarray data, single-cell RNA sequencing, oncogenes, and tumor suppressor genes (TSGs) utilizing bioinformatics techniques. This kind of analysis has not been documented in prior studies. Results We then used a dataset acquired by the Cancer Genome Atlas (TCGA) to confirm our findings. Genes including CYP3A5, PDE8B, AOX1, BNIPL, FADS2, RRM2, ALDH3B2, and GSTM2 may be significant in the diagnosis and treatment of PCa. Conclusion Our objective was to provide new perspectives on the molecular properties and pathways of DEGs in PCa and to uncover potential biomarkers that play a crucial role in the genesis and progression of PCa.

22 July 2025 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
Danial Hashemi KaroiiDanial Hashemi Karoii
Danial Hashemi Karoii
SBSobhan Bavandi
Sobhan Bavandi
AAAli Shakeri Abroudi
Ali Shakeri Abroudi
MDMelika Djamali
Melika Djamali
HAhossein Azizi
hossein Azizi
STSkutella Thomas
Skutella Thomas

30 July 2025 in Antioxidants
Verified
Journal Article
Open access
PDF file
AAAli Shakeri Abroudi
Ali Shakeri Abroudi
HAhossein Azizi
hossein Azizi
VQVyan A. Qadir
Vyan A. Qadir
MDMelika Djamali
Melika Djamali
MAMarwa Fadhil Alsaffar
Marwa Fadhil Alsaffar
STSkutella Thomas
Skutella Thomas
Background: Oxidative stress is a critical factor contributing to male infertility, impairing spermatogonial stem cells (SSCs) and disrupting normal spermatogenesis. This study aimed to isolate and characterize human SSCs and to investigate oxidative stress-related gene expression, protein interaction networks, and developmental trajectories involved in SSC function. Methods: SSCs were enriched from human orchiectomy samples using CD49f-based magnetic-activated cell sorting (MACS) and laminin-binding matrix selection. Enriched cultures were assessed through morphological criteria and immunocytochemistry using VASA and SSEA4. Transcriptomic profiling was performed using microarray and single-cell RNA sequencing (scRNA-seq) to identify oxidative stress-related genes. Bioinformatic analyses included STRING-based protein–protein interaction (PPI) networks, FunRich enrichment, weighted gene co-expression network analysis (WGCNA), and predictive modeling using machine learning algorithms. Results: The enriched SSC populations displayed characteristic morphology, positive germline marker expression, and minimal fibroblast contamination. Microarray analysis revealed six significantly upregulated oxidative stress-related genes in SSCs—including CYB5R3 and NDUFA10—and three downregulated genes, such as TXN and SQLE, compared to fibroblasts. PPI and functional enrichment analyses highlighted tightly clustered gene networks involved in mitochondrial function, redox balance, and spermatogenesis. scRNA-seq data further confirmed stage-specific expression of antioxidant genes during spermatogenic differentiation, particularly in late germ cell stages. Among the machine learning models tested, logistic regression demonstrated the highest predictive accuracy for antioxidant gene expression, with an area under the curve (AUC) of 0.741. Protein oxidation was implicated as a major mechanism of oxidative damage, affecting sperm motility, metabolism, and acrosome integrity. Conclusion: This study identifies key oxidative stress-related genes and pathways in human SSCs that may regulate spermatogenesis and impact sperm function. These findings offer potential targets for future functional validation and therapeutic interventions, including antioxidant-based strategies to improve male fertility outcomes.